Febuxostat is available as 40- and 80-mg tablets. The recommended starting dosage is 40 mg orally once daily. If serum uric acid concentrations are not less than 6 mg/dL after two weeks ...

"Indoco Remedies received final approval of its ANDA (Abbreviated New Drug Application) for Febuxostat tablets 40 mg and 80 mg, which is therapeutically equivalent to the Reference Listed Drug ...

Taking febuxostat places you at a much greater risk of cardiovascular death than taking allopurinol. Febuxostat oral tablet is available ... should stay lower than 6 mg/dL. Your symptoms of ...

The product will be manufactured at Lupin’s Pithampur facility in India. Febuxostat Tablets, 40 mg and 80 mg, are indicated for the chronic management of hyperuricemia in adult patients with ...

Febuxostat tablets in the strengths of 40 mg and 80 mg, Alembic Pharmaceuticals said in a filing to BSE. Quoting IQVIA data, Alembic Pharma said Febuxostat tablets have an estimated market size of ...

Dr Reddy’s Febuxostat tablets are available in 40 mg and 80 mg strengths in bottle count sizes of 30 tablets. Gout patients with established cardiovascular (CV) disease treated with Febuxostat ...

The FDA has approved generic febuxostat 40 mg and 80 mg tablets for managing chronic hyperuricemia. The annual U.S. market for the drug is estimated at $27 million, according to its manufacturer.

The drug, febuxostat (ULORIC, Takeda Pharmaceuticals), is the first new treatment option for this patient population in 40 years. The approved doses are 40 mg and 80 mg. The drug is not ...

Febuxostat (Febucip) is a xanthine oxidase (XO) inhibitor, prescribed for gout and hyperuricemia (high level of uric acid in blood). It decreases the amount of uric acid in blood. The information ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. The information provided on this page is ...

In a trial, investigators randomly assigned 84 patients with stage 3-4 CKD and asymptomatic hyperuricemia to receive febuxostat (40 mg/d) or matching placebo. Half of patients also received stable ...

[38] Both febuxostat 40 and 80 mg can be given to patients with mild-to-moderate renal impairment (CL cr of 30–89 mL/min) without dosage adjustments and are as effective as allopurinol in ...